In mid-June on its website, as well as at the early June ISPE/FDA CGMP Conference, ISPE announced the official launch of its Metrics Pilot Program. The pilot is open to any drug manufacturing company registered with FDA.
Primary objectives of the program include working toward harmonizing definitions around leading and lagging indicators, and testing the feasibility of metrics data collection within and between companies. [See IPQ June 23, 2013 for more on the industry/FDA metrics discussions.][/membership]